There are 42 reps and 5 managers.
The odd thing about it is if you knew you were going to go from 180 to 42...why did you pay 140 people for 2 months for no reason? I mean there must be some reason, but hell if anyone knows what it is. It is just a strange way to do things...I mean it has nothing to do with WARN, because everyone is still retained until March 31st...that's the 2 months of WARN. Just weird.
The other strange thing is the size of these geographies. Alot of Neurologists just won't be called on...you can't hit some of the mid-range targets with those geographies.
Basically, Amgen just quit on Aimovig and that is the bottom line. This is what throwing in the towel looks like. I am sure somebody will buy it and if you are one of the 42 reps remaining, it might be fine for you - as long as you don't mind all the travel. I mean somebody somewhere is going to sell it and someone will RX it...but you probably have much better jobs with much more support...it will be interesting to see what ends up happening. I suspect the initial 42 will be much smaller 3 months from now as people find other opportunities elsewhere